Personalized Microneedling Protocols For Different Scar Types

https://en.wikipedia.org/wiki/Microneedles

Scarring is not a monolithic entity. Classified by pathophysiology into atrophic, hypertrophic, and keloidal scars, each demands distinct diagnostic and therapeutic approaches. Microneedling's adjustable parameters enable precise, personalized protocols-truly "treating according to type."

1. Atrophic Scars (Depressed Scars)

Common after acne, varicella, or trauma, these present as dermal depressions caused by collagen and elastin loss. The goal is "volume restoration" via collagen induction. Protocols typically use needles 0.5–1.5 mm in length, adjusted for depression depth. Sessions occur every 4–6 weeks, with 3–5 sessions constituting a course. For deep "icepick" scars, combining microneedling with high-concentration Hyaluronic Acid or Platelet-Rich Plasma (PRP) infusion enhances tissue filling. Clinical data indicates >70% of patients achieve >50% improvement in depression depth after three sessions.

2. Hypertrophic Scars

Arising post-burn, surgery, or injury, these scars are raised but confined to the original wound boundaries. Pathophysiology involves hyperactive fibroblasts with excessive collagen synthesis. Treatment must balance "suppression" and "remodeling." Needle lengths of 0.5–1.0 mm are used alongside infusions of Triamcinolone or 5-Fluorouracil. Triamcinolone inhibits fibroblast proliferation and inflammation; 5-FU blocks DNA synthesis. Sessions are spaced 3–4 weeks apart (4–6 total). Outcomes include 60–80% reduction in scar height, softening in texture, and normalization of color.

3. Keloids

These aggressive scars extend beyond the original wound margins in a claw-like fashion and carry a high recurrence risk post-excision. Microneedling serves primarily as an adjunct for drug delivery. Standard practice involves surgical excision or cryotherapy to remove the bulk, followed immediately by microneedling with drug infusion to prevent recurrence. Needles (1.0–2.0 mm) ensure deep penetration. A common cocktail includes Triamcinolone and 5-FU, sometimes with Botulinum Toxin to reduce tension. Post-procedure pressure therapy and regular follow-up are essential. Studies show microneedling combination therapy can slash keloid recurrence rates from ~45% (surgery alone) to <15%.

This stratified approach embodies modern scar management: no single therapy fits all. Precision diagnosis and individualized combinations are key. With advancing microneedle materials and delivery systems, "one needle, one protocol" customization is on the horizon.